Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Axovant Sciences: Breaking Down What's Seemingly Broken For Further Insight [Seeking Alpha]

Axon Enterprise, Inc. (AXON) 
Last axon enterprise, inc. earnings: 2/7 04:15 pm Check Earnings Report
Company Research Source: Seeking Alpha
Axovant Sciences: Breaking Down What's Seemingly Broken For Further InsightSummaryAxovant was a big success at its IPO due to the significant potential of its investigational drugs. Nevertheless, the clinical binaries were not in the company’s favor.Intepirdine was unable to post the strong (phase II and III) data in various franchises.Nelotanserin also delivered subpar results in its phase II clinical program for Lewy Body dementia with visual hallucination.There is still a chance that nelotanserin can deliver positive outcomes for the other trial studying Lewy body dementia with REM behavior disorder. Show less Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AXON alerts
Opt-in for
AXON alerts

from News Quantified
Opt-in for
AXON alerts

from News Quantified